share_log
Moomoo 24/7 ·  Apr 1 08:10
NeuroBo Pharmaceuticals Completes Enrollment Of Part 1 Of Its Phase 2a Clinical Trial Evaluating DA-1241 For Treatment Of MASH
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment